SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artÝculo

ALVES DE CARVALHO, M.ª do S. et al. Risk factors associated with hepatic steatosis: a study in patients in the Northeast Brazil. Nutr. Hosp. [online]. 2012, vol.27, n.4, pp.1344-1350. ISSN 0212-1611.

    1. Adams LA, Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabet Med 2005; 22: 1129-33. [ Links ]

    2. Sass DA, Chang P, Chopra KB. Nonalcoholic Fatty Liver Disease: A clinical review. Dig Dis Sci 2005;50: 171-80. [ Links ]

    3. Bellentani S, Saccoccio G, Masultti F, Croce LS, Brandi G, Sasso F. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-7. [ Links ]

    4. Browning JD, Szczepaniak LS, Dobbins R. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 387-395. [ Links ]

    5. Stranges S, Dorn JM, Muti P et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 2004; 39: 754-763. [ Links ]

    6. Angulo P. Nafld, obesity, and bariatric surgery. Gastroenterology 2006; 130: 1848-1852. [ Links ]

    7. Kim DH, Choi SY, Park EH, Yang JI, Kim W, Kim YJ, Yoon JH, Lee HS, Shin CS, Cho SH, Oh BH. Non-alcoholic fatty liver disease (NAFLD) as a risk factor of coronary heart disease; relation of NAFLD to coronary artery calcification score by multi- detector computed tomography: The 43rd Annual Meeting of the European Association for the Study of the Liver Milan, Italy, 2008. [ Links ]

    8. Hamer WO, Aguirre DA, Casola G, Lavine JE, Wonckhaus M, Sirlin CB. Fatty Liver: imaging patterns and pitfalls. Radiographics 2006; 26: 1637-53. [ Links ]

    9. Farrel GC, Liddle C. Drugs and liver updated. Semin Liver Dis 2002; 22 (2): 109-13. [ Links ]

    10. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Abridged ,1991, 90 p. [ Links ]

    11. WHO. World Health Organization. Obesity epidemic puts millions at risk from related disease. WHO Pres Relate 1997; 46: 12. [ Links ]

    12. Lipschitz DA. Screning for nutritional status in the elderly. Primary Care 1994; 21:55-67. [ Links ]

    13. WHO. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva, 1998, pp. 4-48. [ Links ]

    14. Joint-The seventh Report of the Joint national Committee on Prevent, Detection, Evaluation and Treatment of High Blood Pressure. U.S. Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute National High Blood Pressure Education Program. NIH Publication No. 04-5230-August 2004. [ Links ]

    15. American Diabetes Association: Nutrition principles and recommendations in diabetes (Position Statement). Diabetes Care 2004; 27 (Suppl. 1): S36-S46. [ Links ]

    16. NCEP. National Cholesterol Education Program (Expert Panel on Detection, evoluation, and treatment of high blood cholesterol in adults (Adults Treatement Panel III). Third Report of the National Cholesterol Education Program (NCEP), final report. Circulation 2002; 106: 3143-3421. [ Links ]

    17. Popkin BM,Gordon-Larsen P. The nutrition transition: world-wide obesity dynamic and their determinants. Int J Obes Relat Disord 2004; 28 (Suppl. 3): 2-9. [ Links ]

    18. Furuta K, Sato S, Ishine J, Okamoto E, Tobita H, Miyake T, Ishihara S, Amano Y, Adachi K, Maruyama R, Kinoshita Y. Predictive factors for severity of liver histology in patients with non-alcoholic steatohepatitis: Usefulness of measurement of arteriosclerosis indicators: Digestive Disease Week 2008. San Diego, CA, 2008. [ Links ]

    19. Maher JJ. Why do some alcoholics develop liver disease while others o not? AASLD Postgraduate Course (Handouts) 2005; 85-91. [ Links ]

    20. McKillop IH, Schrum LW. Alcohol and liver cancer. Alcohol 2005; 35: 195-203. [ Links ]

    21. Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev 2004; 5: 27-42. [ Links ]

    22. Day CP. Pathogenesis of steatohepatitis. Best Pratice & Research Clinical Gastroenterology 2002; 16 (5): 663-78. [ Links ]

    23. Day CP, Saksena S. Nonalcoholic steatohepatitis: definitions and pathogenesis. J Gastroenterol Hepatol 2002; 17: S384. [ Links ]

    24. Scheen AJ, Luyckx FH. Obesity and liver disease. J Clin Endocrinol Metab 2002; 6: 703-716. [ Links ]

    25. Gunji T, Matsuhashi, Sato H, Lijima K, Fujibayashi K, Okumura M, Sasabe N, Urabe A. Risk factors for serum alanine aminotransferase elevation: A cross-sectional study of healthly adult males in Tokyo, Japan. Dig. Liver Dis, 2010. [ Links ]

    26. Donati G, Stagni B, Piscaglia F, Venturoli, N, Morselli-Lobate, AM, Rasciti L, Bolondi, L. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut 2004; 53: 1020-23. [ Links ]

    27. Brookes MJ, Cooper BT. Hypertension and fatty liver: guilty by association? J Hum Hypertens 2007; 21: 264-70. [ Links ]

    28. Amarapurkar DN, Amarapurkar AD, Aptel N D, Agal S, Baigal R, Gupte P, Pramanik S. Nonalcoholoc steatohepatitis (NASH) with diabetes: predictors of liver Fibrosis. Annals of Hepatology 2006; 5-(1): 30-3. [ Links ]

    29. Pagano G, Pacini G, Musso G et al. Nonalcoholic steatohep-atitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002; 35:367-372. [ Links ]

    30. Cotrim, HP, Carvalho, FM, Siqueira, AC, Lordelo, M. Rocha, R. Freitas, LA Nonalcoholic fatty liver and insulin resistance among petrochemical workers. JAMA 2005; 294 (13): 1618-1620. [ Links ]